2024-517652-35-00CompletedPhase 1
A Clinical Study to Compare the Impact of Multiple-dose Oral Administration of Macitentan, 10 mg versus 75 mg on Endothelin-1 Clearance, Endothelial Function, and Hemodynamics in Healthy Participants
Source: EU CTIS (euclinicaltrials.eu) · Last updated 4 Feb 2026
- Status (registry)
- Completed
- Phase (registry)
- Phase 1
- Study type
- Interventional
- Enrollment
- 20 (actual)
- First submitted
- 30 Sept 2024
- Start date
- 1 Apr 2025
- Lead sponsor
- Actelion Pharmaceuticals Ltd.
- EU CT number
- 2024-517652-35-00
What you commit to
- Study type: Interventional · Phase 1
- Participants enrolled: 20
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of EU CTIS (euclinicaltrials.eu). It describes the study design.
Sites (1)
Sites in registry order. Save your city in your profile to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Centre Hospitalier Universitaire Rouen | Rouen Cedex | France | Completed |
This page is information, not medical advice. Discuss any trial with your doctor.